Ryan Allway January 10th, 2022 Psychedelics Research will focus on developing novel patentable psychedelics as potential drug candidates TORONTO, Jan. 10, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF) (“Clearmind” or the “Company”), a psychedelic medicine biotech company focused on the discovery and development of novel... Read more
Clearmind Medicine To Fund Second R&D Partnership With Hebrew University’s Technology Transfer Company
September 27, 2021
Ryan Allway September 27th, 2021 Psychedelics Toronto, Ontario–(Newsfile Corp. – September 27, 2021) – Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the “Company“), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, is pleased to announce... Read more
